Tufts Medicine
Buying intent
27 tracked signals | Top 15 topics are below | Marketing is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Tufts Medicine's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
12d ago
13d ago
15d ago
18d ago
17d ago
10d ago
17d ago
22d ago
16d ago
10d ago
17d ago
22d ago
23d ago
25d ago
26d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Tufts Medicine
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
11 people across every department at Tufts Medicine, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileTufts Medicine is a leading integrated health system bringing together the best of academic and community health care to deliver exceptional, connected and accessible care experiences to consumers across Massachusetts. Comprised of Tufts Medical Center, Lowell General Hospital, MelroseWakefield Healthcare, an expansive home care network and a large clinically integrated physician network, Tufts Me
Top accounts researching Tufts Medicine
names withheld on the public pageThese are companies whose own people brought up Tufts Medicine unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
1,943 companies · 7,980 people are researching Hospital
Tufts Medicine's own team shows 7 signals on this topic. No one outside Tufts Medicine has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Artificial Intelligence151,426 cos · 839,012 people
- Career Development71,482 cos · 516,730 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Leadership — 1 person; Marketing — 1 person; Operations — 1 person
What's been said
public posts by Tufts Medicine's teamNo public post naming Tufts Medicine has surfaced in the past year, so this is what Tufts Medicine's own team is posting about publicly — their topics, in their words.
Thank you, OncoDaily , Vumedi Oncology , Jason Binder . Tufts Medical Center and Tufts University School of Medicine
May 2026🧬 One Pulse, Permanent Lockdown: The Future of Biocontainment The "kill switch" just got a massive upgrade. 🛡️ A research team at Seoul National University has developed a CRISPR-based system that doesn't just inhibit engineered microbes—it fundamentally rewrites their ability to exist once their job is done. Published in Nucleic Acids Research, this platform is a game-changer for industrial biotechnology and live biotherapeutics. Why this matters: Traditional biocontainment often relies on DNA cutting, which can be leaky or prone to mutations. This new system uses base editing to target the "start codons" of three essential genes simultaneously. The Highlights: • Permanent Inactivation: It flips the genetic switch from "Go" to "Stop" without cutting DNA. • Incredible Precision: Achieves escape frequencies of \bm{10^{-8}} or lower—meeting strict NIH biosafety thresholds. • Rapid Response: The entire shutdown occurs within just one hour. • Versatile: Proven effective across multiple E. coli strains without interfering with the microbe’s primary engineered functions. The Big Picture 🌍 As we move toward "living medicines" and large-scale bio-manufacturing, public and regulatory trust is everything. This platform provides a robust "emergency brake," ensuring that engineered organisms stay exactly where they belong. While ecological validation is the next hurdle, this is a significant leap toward safer, more reliable synthetic biology. #Sang Woo Seo Read the full study in Nucleic Acids Research. #SyntheticBiology #CRISPR #Biotech #BioSafety #Innovation #Genomics #SeoulNationalUniversity Published in Nucleic Acids Research, Vol. 54, Issue 8, May 8, 2026 (article gkag422). DOI: 10.1093/nar/gkag422. Funded by NRF Korea and the Samsung Research Funding & Incubation Center.
May 2026I normally keep my creative work separate from medicine — but sometimes the arts become another way to support the people and causes we care about most. I entered People’s Artist because creativity, music, and storytelling are part of how I stay grounded outside of clinical medicine and leadership. If I were fortunate enough to win, the proceeds would go toward the Tufts Medical Center Neurology Resident Wellness Fund. #Neurology residents carry enormous emotional, intellectual, and clinical responsibility while caring for patients with some of the most complex neurologic diseases. Preserving and supporting the wellbeing of our trainees matters deeply. Burnout in neurology is real, and investing in resident wellness is one small but meaningful way to help sustain the future of our field. If you happen to have a Facebook account and would like to support the effort, please consider voting. Casting ONE VOTE IS FREE. Thank you for supporting both the creative arts and the next generation of neurologists. Here is the link to vote: https://lnkd.in/en2u6aP4 There are 48 hours left to vote. Jason Binder Christopher Schuler Shailesh Jejurikar Juliana Nunes Allison (Cooper) Zuber Michelle Cooper Mark A. Exley Raul Perez-Olle Alexandra Adler, MD Akanksha Sharma Achyut Saroj, PhD, BCMAS Midhun Ben Thomas Claudia Rebola Laura C. Duncan MHA, MHI, FACHE Caitlin Rivet, BSN, RN, CENP Lise Alschuler, ND, eMBA, FABNO Gene Hobbs Heekyoung Jung Imo Akpan, MD Jess G. Scott L. Pomeroy Matt Dun OAM, PhD Michael Stanley Michael Martin, MHA, CPRP Olga Taran Patrick Kent, MBA, PMP Ravi Samy Shira Doron Ting Bao Shankar Rao Rohan Rao Ugur Sener Maxwell A. Xu (MAX) Valerie Yang, MB BChir, PhD Yasmin Khakoo, MD, FCNS, FAAN, FAAP Zack Harwood
May 2026